CGRP receptor antagonists: design and screening

Bibliography

• Poyner DR, Sexton PM, Marshall I, International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002;54(2):233-46
   PubMed Web of Science ®Google Scholar
• McLatchie LM, Fraser NJ, Main MJ, RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998;393(6683):333-9
   PubMed Web of Science ®Google Scholar
• Recober A, Russo AF. Calcitonin gene-related peptide: an update on the biology. Curr Opin Neurol 2009;22(3):241-6
   PubMed Web of Science ®Google Scholar
• Wimalawansa SJ. Calcitonin gene-related peptide and its receptors: Molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 1996;17:533-85
   PubMed Web of Science ®Google Scholar
• Lu JT, Son YJ, Lee J, Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci 1999;14(2):99-120
   PubMed Web of Science ®Google Scholar
• Gangula PR, Zhao H, Supowit SC, Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertension 2000;35(1 Pt 2):470-5
   PubMed Web of Science ®Google Scholar
• Li J, Zhao H, Supowit SC, Activation of the renin-angiotensin system in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. J Hypertens 2004;22(7):1345-9
   PubMed Web of Science ®Google Scholar
• Kurihara H, Shindo T, Oh-Hashi Y, Targeted disruption of adrenomedullin and alphaCGRP genes reveals their distinct biological roles. Hypertens Res 2003;26 Suppl:S105-8
   PubMedGoogle Scholar
• Shindo T, Kurihara Y, Nishimatsu H, Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2001;104(16):1964-71
   PubMed Web of Science ®Google Scholar
• Chai W, Mehrotra S, Jan Danser AH, Schoemaker RG. The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts. Eur J Pharmacol 2006;531(1-3):246-53
   PubMed Web of Science ®Google Scholar
• Ohno T, Hattori Y, Komine R, Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology 2008;134(1):215-25
   PubMed Web of Science ®Google Scholar
• Carpenter KA, Schmidt R, von Mentzer B, Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains. Biochemistry 2001;40(28):8317-25
   PubMed Web of Science ®Google Scholar
• Lang M, De Pol S, Baldauf C, Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor. J Med Chem 2006;49(2):616-24
   PubMed Web of Science ®Google Scholar
• Banerjee S, Evanson J, Harris E, Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding. BMC Pharmacol 2006;6:9
   PubMedGoogle Scholar
• Chiba T, Yamaguchi A, Yamatani T, Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol 1989;256(2 Pt 1):E331-5
   PubMed Web of Science ®Google Scholar
• Hoare SR. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 2005;10(6):417-27
   PubMed Web of Science ®Google Scholar
• Lang M, Beck-Sickinger AG. Structure-activity relationship studies: methods and ligand design for G-protein coupled peptide receptors. Curr Protein Pept Sci 2006;7(4):335-53
   PubMed Web of Science ®Google Scholar
• Taylor CK, Smith DD, Hulce M, Abel PW. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors. J Pharmacol Exp Ther 2006;319(2):749-57
   PubMed Web of Science ®Google Scholar
• Ashina S, Bendtsen L, Ashina M, Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 2006;26(8):940-8
   PubMed Web of Science ®Google Scholar
• Bellamy JL, Cady RK, Durham PL. Salivary Levels of CGRP and VIP in Rhinosinusitis and Migraine Patients. Headache J Head Face Pain 2006;46(1):24-33
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56
   PubMed Web of Science ®Google Scholar
• Lassen LH, Haderslev PA, Jacobsen VB, CGRP may play a causative role in migraine. Cephalalgia 2002;22(1):54-61
   PubMed Web of Science ®Google Scholar
• Chiba T, Yamaguchi A, Yamatani T, Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol 1989;256(2 Pt 1):E331-5
   PubMed Web of Science ®Google Scholar
• Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 2004;84(3):903-34
   PubMed Web of Science ®Google Scholar
• Mogil JS, Miermeister F, Seifert F, Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci USA 2005;102(36):12938-43
   PubMed Web of Science ®Google Scholar
• Okajima K, Harada N. Regulation of inflammatory responses by sensory neurons: molecular mechanism(s) and possible therapeutic applications. Curr Med Chem 2006;13(19):2241-51
   PubMed Web of Science ®Google Scholar
• Bourdu S, Dapoigny M, Chapuy E, Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 2005;128(7):1996-2008
   PubMed Web of Science ®Google Scholar
• Arnalich F, Hernanz A, Jimenez M, Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock. Regul Pept 1996;65(2):115-21
   PubMed Web of Science ®Google Scholar
• Arden WA, Fiscus RR, Wang X, Elevations in circulating calcitonin gene-related peptide correlate with hemodynamic deterioration during endotoxic shock in pigs. Circ Shock 1994;42(3):147-53
   PubMedGoogle Scholar
• Monneret G, Pachot A, Laroche B, Procalcitonin and calcitonin gene-related peptide decrease LPS-induced tnf production by human circulating blood cells. Cytokine 2000;12(6):762-4
   PubMed Web of Science ®Google Scholar
• Wyon Y, Spetz AC, Hammar M, Urinary excretion of calcitonin gene-related peptide in males with hot flushes after castration for carcinoma of the prostate. Scand J Urol Nephrol 2001;35(2):92-6
   PubMed Web of Science ®Google Scholar
• Wyon YA, Spetz AC, Theodorsson GE, Hammar ML. Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause 2000;7(1):25-30
   PubMed Web of Science ®Google Scholar
• Schinke T, Liese S, Priemel M, Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner Res 2004;19(12):2049-56
   PubMed Web of Science ®Google Scholar
• Wedemeyer C, Neuerburg C, Pfeiffer A, Polyethylene particle-induced bone resorption in alpha-calcitonin gene-related peptide-deficient mice. J Bone Miner Res 2007;22(7):1011-19
   PubMed Web of Science ®Google Scholar
• Bowe JE, Li XF, Kinsey-Jones JS, Calcitonin gene-related peptide-induced suppression of luteinizing hormone pulses in the rat: the role of endogenous opioid peptides. J Physiol 2005;566(Pt 3):921-8
   PubMed Web of Science ®Google Scholar
• Schorscher-Petcu A, Austin JS, Mogil JS, Quirion R. Role of Central Calcitonin Gene-Related Peptide (CGRP) in Locomotor and Anxiety- and Depression-Like Behaviors in Two Mouse Strains Exhibiting a CGRP-Dependent Difference in Thermal Pain Sensitivity. J Mol Neurosci 2009
   PubMed Web of Science ®Google Scholar
• Toda M, Suzuki T, Hosono K, Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide. Proc Natl Acad Sci USA 2008;105(36):13550-5
   PubMed Web of Science ®Google Scholar
• Dennis T, Fournier A, Cadieux A, hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 1990;254(1):123-8
   PubMed Web of Science ®Google Scholar
• Choksi T, Hay DL, Legon S, Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines. Br J Pharmacol 2002;136(5):784
   PubMed Web of Science ®Google Scholar
• Christopoulos G, Perry KJ, Morfis M, Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999;56(1):235-42
   PubMed Web of Science ®Google Scholar
• Hay DL, Christopoulos G, Christopoulos A, Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol Pharmacol 2005;67(5):1655-65
   PubMed Web of Science ®Google Scholar
• Hay DL, Poyner DR, Quirion R. International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor. Pharmacol Rev 2008;60(2):143-5
   PubMed Web of Science ®Google Scholar
• Fraser NJ, Wise A, Brown J, The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol Pharmacol 1999;55(6):1054-9
   PubMed Web of Science ®Google Scholar
• Heroux M, Hogue M, Lemieux S, Bouvier M. Functional Calcitonin Gene-related Peptide Receptors Are Formed by the Asymmetric Assembly of a Calcitonin Receptor-like Receptor Homo-oligomer and a Monomer of Receptor Activity-modifying Protein-1. J Biol Chem 2007;282(43):31610-20
   PubMed Web of Science ®Google Scholar
• Sexton PM, Christopoulos G, Christopoulos A, Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis. Crit Care Med 2008;36(5):1637-40
   PubMed Web of Science ®Google Scholar
• Prado MA, Evans-Bain B, Oliver KR, Dickerson IM. The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides 2001;22(11):1773-81
   PubMed Web of Science ®Google Scholar
• Doods H, Hallermayer G, Wu D, Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 2000;129(3):420-3
   PubMed Web of Science ®Google Scholar
• Olesen J, Diener HC, Husstedt IW, Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004;350(11):1104-10
   PubMed Web of Science ®Google Scholar
• Rudolf K, Eberlein W, Engel W, Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidi nyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine. J Med Chem 2005;48(19):5921-31
   PubMed Web of Science ®Google Scholar
• Paone DV, Shaw AW, Nguyen DN, Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974). J Med Chem 2007;50(23):5564-7
   PubMed Web of Science ®Google Scholar
• Roller S, Cui D, Laspina C, Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences. Xenobiotica 2009;39(1):33-45
   PubMed Web of Science ®Google Scholar
• Ho TW, Ferrari MD, Dodick DW, Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 2008;372(9656):2115-23
   PubMed Web of Science ®Google Scholar
• Degnan AP, Chaturvedula PV, Conway CM, Discovery of (R)-4-(8-fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-in dazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidi ne-1-carboxamide (BMS-694153): a potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and efficient intranasal exposure. J Med Chem 2008;51(16):4858-61
   PubMed Web of Science ®Google Scholar
• Miller LJ. Informed development of drugs acting at family B G protein-coupled receptors. Ann NY Acad Sci 2008;1144:203-9
   PubMed Web of Science ®Google Scholar
• Mallee JJ, Salvatore CA, LeBourdelles B, Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 2002;277:14294-8
   PubMed Web of Science ®Google Scholar
• Hay DL, Poyner DR, Sexton PM. GPCR modulation by RAMPs. Pharmacol Ther 2006;109(1-2):173-97
   PubMed Web of Science ®Google Scholar
• Salvatore CA, Mallee JJ, Bell IM, Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor. Biochemistry 2006;45(6):1881-7
   PubMed Web of Science ®Google Scholar
• Kusano S, Kukimoto-Niino M, Akasaka R, Crystal structure of the human receptor activity-modifying protein 1 extracellular domain. Protein Sci 2008;17(11):1907-14
   PubMed Web of Science ®Google Scholar
• Christopoulos A, Christopoulos G, Morfis M, Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 2003;278(5):3293-7
   PubMed Web of Science ®Google Scholar
• Bouschet T, Martin S, Henley JM. Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci 2005;118(Pt 20):4709-20
   PubMed Web of Science ®Google Scholar
• Sexton PM, Poyner DR, Simms J, Modulating receptor function through RAMPs: can they represent drug targets in themselves? Drug Discov Today 2009;14(7-8):413-19
   PubMed Web of Science ®Google Scholar
• Kuwasako K, Kitamura K, Nagoshi Y, Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J Biol Chem 2003;278(25):22623-30
   PubMed Web of Science ®Google Scholar
• Simms J, Hay DL, Bailey RJ, Structure-function analysis of RAMP1 by alanine mutagenesis. Biochemistry 2009;48(1):198-205
   PubMed Web of Science ®Google Scholar
• Hay DL, Christopoulos G, Christopoulos A, Sexton PM. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1- [(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2 H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors–the role of receptor activity modifying protein 1. Mol Pharmacol 2006;70(6):1984-91
   PubMed Web of Science ®Google Scholar
• Pioszak AA, Xu HE. Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci USA 2008;105(13):5034-9
   PubMed Web of Science ®Google Scholar
• Sun C, Song D, Davis-Taber RA, Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS. Proc Natl Acad Sci USA 2007;104(19):7875-80
   PubMed Web of Science ®Google Scholar
• Grace CR, Perrin MH, Gulyas J, Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand. Proc Natl Acad Sci USA 2007
   PubMedGoogle Scholar
• Parthier C, Kleinschmidt M, Neumann P, Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci USA 2007;104(35):13942-7
   PubMed Web of Science ®Google Scholar
• Parthier C, Reedtz-Runge S, Rudolph R, Stubbs MT. Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem Sci 2009;34(6):303-10
   PubMed Web of Science ®Google Scholar
• Ittner LM, Koller D, Muff R, The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. Biochemistry 2005;44(15):5749-54
   PubMed Web of Science ®Google Scholar
• Salvatore CA, Mallee JJ, Bell IM, Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor. Biochemistry 2006;45(6):1881-7
   PubMed Web of Science ®Google Scholar
• Aiyar N, Daines RA, Disa J, Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J Pharmacol Exp Ther 2001;296(3):768-75
   PubMed Web of Science ®Google Scholar
• Conner AC, Simms J, Howitt SG, Multiple residues within the second extracellular loop of the CL receptor are required for receptor activation by CGRP pA2. Online 2005;3:99
   Google Scholar
• Edvinsson L, Nilsson E, Jansen-Olesen I. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 2007;150(5):633-40
   PubMed Web of Science ®Google Scholar
• Vater A, Jarosch F, Buchner K, Klussmann S. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. Nucleic Acids Res 2003;31(21):e130
   PubMedGoogle Scholar
• Roldos V, Martin-Santamaria S, Julian M, Small-molecule negative modulators of adrenomedullin: design, synthesis, and 3D-QSAR study. ChemMedChem 2008;3(9):1345-55
   PubMed Web of Science ®Google Scholar
• Zhang XP, Hintze TH. cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation. Am J Physiol Heart Circ Physiol 2006;290(6):H2376-84
   PubMed Web of Science ®Google Scholar
• Wellman GC, Quayle JM, Standen NB. ATP-sensitive K+ channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 1998;507(Pt 1):117-29
   PubMed Web of Science ®Google Scholar
• Simonetti M, Giniatullin R, Fabbretti E. Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons. J Biol Chem 2008;283(27):18743-52
   PubMed Web of Science ®Google Scholar
• Aiyar N, Disa J, Stadel JM, Lysko PG. Calcitonin gene-related peptide receptor independently stimulates 3′,5′-cyclic adenosine monophosphate and Ca2+ signaling pathways. Mol Cell Biochem 1999;197(1-2):179-85
   PubMed Web of Science ®Google Scholar
• Burns DM, Stehno-Bittel L, Kawase T. Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and -dependent mechanisms. Am J Physiol Cell Physiol 2004;287(2):C457-67
   PubMed Web of Science ®Google Scholar
• Dong YL, Green KE, Vegiragu S, Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies. J Clin Endocrinol Metab 2005;90(4):2336-43
   PubMed Web of Science ®Google Scholar
• Drissi H, Lieberherr M, Hott M, Calcitonin gene-related peptide (CGRP) increases intracellular free Ca2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4). Cytokine 1999:200-7
   PubMed Web of Science ®Google Scholar
• Giniatullin R, Di Angelantonio S, Marchetti C, Calcitonin gene-related peptide rapidly downregulates nicotinic receptor function and slowly raises intracellular Ca2+ in rat chromaffin cells in vitro. J Neurosci 1999;19(8):2945-53
   PubMed Web of Science ®Google Scholar
• Herzog M, Scherer EQ, Albrecht B, CGRP receptors in the gerbil spiral modiolar artery mediate a sustained vasodilation via a transient cAMP-mediated Ca2+-decrease. J Membr Biol 2002;189(3):225-36
   PubMed Web of Science ®Google Scholar
• Morara S, Wang LP, Filippov V, Calcitonin gene-related peptide (CGRP) triggers Ca2+ responses in cultured astrocytes and in Bergmann glial cells from cerebellar slices. Eur J Neurosci 2008;28(11):2213-20
   PubMed Web of Science ®Google Scholar
• Vause CV, Durham PL. CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogen-activated protein kinase pathways. J Neurochem 2009;110(3):811-21
   PubMed Web of Science ®Google Scholar
• Schaeffer C, Vandroux D, Thomassin L, Calcitonin gene-related peptide partly protects cultured smooth muscle cells from apoptosis induced by an oxidative stress via activation of ERK1/2 MAPK. Biochim Biophys Acta 2003;1643(1-3):65-73
   PubMed Web of Science ®Google Scholar
• Yu XJ, Li CY, Wang KY, Dai HY. Calcitonin gene-related peptide regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes by activation of ERK1/2 MAPK. Regul Pept 2006;137(3):134-9
   PubMed Web of Science ®Google Scholar
• Conner M, Hicks MR, Dafforn T, Functional and biophysical analysis of the C-terminus of the CGRP-receptor; a family B GPCR. Biochemistry 2008;47(32):8434-44
   PubMed Web of Science ®Google Scholar
• Disa J, Dang K, Tan KB, Aiyar N. Interaction of adrenomedullin with calcitonin receptor in cultured human breast cancer cells, T 47D. Peptides 1998;19(2):247-51
   PubMed Web of Science ®Google Scholar
• Hilairet S, Belanger C, Bertrand J, Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin. J Biol Chem 2001;276:42182-90
   PubMed Web of Science ®Google Scholar
• Schindler M, Doods HN. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [3H]BIBN4096BS. Eur J Pharmacol 2002;442(3):187-93
   PubMed Web of Science ®Google Scholar
• Salvatore CA, Hershey JC, Corcoran HA, Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine. J Pharmacol Exp Ther 2008;324(2):416-21
   PubMed Web of Science ®Google Scholar
• Robinson SD, Aitken JF, Bailey RJ, Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors; identification, pharmacological characterization and interactions with position 74 in RAMP1/3. J Pharmacol Exp Ther 2009
   PubMedGoogle Scholar
• Runge S, Thogersen H, Madsen K, Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 2008;283(17):11340-7
   PubMed Web of Science ®Google Scholar